Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ANTAGONISTAS, ANTI-INFLAMATÓRIOS, ASMA, RECEPTORES, HISTAMINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA, Michelle F. et al. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential. Frontiers in Pharmacology, v. 8, 2017Tradução . . Disponível em: https://doi.org/10.3389/fphar.2017.00825. Acesso em: 21 maio 2024.APA
Corrêa, M. F., Barbosa, Á. J. R., Teixeira, L. B., Duarte, D. A., Simões, S. C., Silva, L. T. P. e, et al. (2017). Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential. Frontiers in Pharmacology, 8. doi:10.3389/fphar.2017.00825NLM
Corrêa MF, Barbosa ÁJR, Teixeira LB, Duarte DA, Simões SC, Silva LTP e, Balbino AM, Landgraf RG, Bouvier M, Costa Neto CM, Fernandes JPS. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 maio 21 ] Available from: https://doi.org/10.3389/fphar.2017.00825Vancouver
Corrêa MF, Barbosa ÁJR, Teixeira LB, Duarte DA, Simões SC, Silva LTP e, Balbino AM, Landgraf RG, Bouvier M, Costa Neto CM, Fernandes JPS. Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential [Internet]. Frontiers in Pharmacology. 2017 ; 8[citado 2024 maio 21 ] Available from: https://doi.org/10.3389/fphar.2017.00825